NCT06896682 Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?
| NCT ID | NCT06896682 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Esbjerg Hospital - University Hospital of Southern Denmark |
| Condition | Postbariatric Hypoglycemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-07-08 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-07-08 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about how bariatric surgery affects the metabolism of cortisol. The main question it aims to answer is whether changes in cortisol contribute to the development of reactive hypoglycemia? 100 individuals who have previously undergone bariatric surgery, are planned to be included.
Eligibility Criteria
Inclusion Criteria: Participants must have undergone one of the following bariatric procedures at least 12 months prior: * Roux-en-Y gastric bypass * Gastric sleeve Exclusion Criteria * Pregnancy and breastfeeding * Nephrotic syndrome (kidney disease with protein loss in urine), liver cirrhosis, or severe malnutrition, as these conditions reduce cortisol-binding globulin (CBG) levels, affecting total cortisol concentration * Use of corticosteroid medications, such as prednisolone * Use of opiod-containing medication * Use of medications containing estrogen, such as hormone therapy for menopause * Known adrenal disease affecting cortisol metabolism, including autonomous cortisol production and Cushing's syndrome * Diabetes that does not require medical treatment * Previously diagnosed reactive hypoglycemia after bariatric surgery requiring medical treatment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06896682 clinical trial?
This trial is open to participants of all sexes, studying Postbariatric Hypoglycemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06896682 currently recruiting?
Yes, NCT06896682 is actively recruiting participants. Contact the research team at charlotte.ron.stolberg@rsyd.dk for enrollment information.
Where is the NCT06896682 trial being conducted?
This trial is being conducted at Esbjerg, Denmark.
Who is sponsoring the NCT06896682 clinical trial?
NCT06896682 is sponsored by Esbjerg Hospital - University Hospital of Southern Denmark. The trial plans to enroll 100 participants.